Over the past decade, hospital discharges for hyperplasia of the prostate in Mexico have shown a fluctuating trend. In 2023, the volume stood at 22.04 thousand hospital discharges. Year-on-year variations indicate periodic declines and spikes, with notable drops in 2020 due to the COVID-19 pandemic and subsequent recovery in the following years. Over the last two years, there has been a positive recovery with a 42.86% increase in 2022 and a 14.22% increase in 2023. The 5-year CAGR has plateaued at 0.58%, reflecting stabilization in recent years. Forecasts predict minor increases, with a forecast 5-year CAGR of 0.01% and an overall growth rate of 0.07% by 2028.

Future trends to watch for:

Technological advancements in less invasive treatments for hyperplasia of the prostate.
The impact of aging demographics on the incidence rates.
Healthcare policy changes affecting patient access to medical care and early treatment.
Potential long-term effects of the COVID-19 pandemic on healthcare systems and patient behavior.